Reducing Dental Anxiety in Children Using a Mobile Health App: Usability and User Experience Study.

BACKGROUND: Dentistry interventions cause common anxiety and fear problems in children (6-11 years), and according to scientific evidence, this causes a decrease in their quality of life. Therapies mediated by IT-based tools have been shown to positively influence children's mood based on distraction as well as relaxing activities, but there is no evidence of their use to reduce dental anxiety in children. OBJECTIVE: The aim of this study was to answer the following research question: Does our new children-centered codesign methodology contribute to achieving a usable mobile-based product with a highly scored user experience? METHODS: A mobile health app was developed to reduce dental anxiety in children using rapid application development following the usage-centered design methodology. Structured interviews were conducted to test the usability and user experience of the app prototype among 40 children (n=20, 50%, boys and n=20, 50%, girls; age 6-11 years) using a children-adapted questionnaire and the 7-point Single Ease Question rating scale. The Smiley Faces Program-Revised questionnaire was used to assess the level of dental anxiety in participants. RESULTS: There were no significant differences between girls and boys. The task completion rate was 95% (n=19) for children aged 6-8 years (group 1) and 100% (n=20) for children aged 9-11 years (group 2). Group 1 found watching the relaxing video (task C) to be the easiest, followed by playing a video minigame (task B) and watching the narrative (task A). Group 2 found task C to be the easiest, followed by task A and then task B. The average time spent on the different types of tasks was similar in both age groups. Most of the children in both age groups were happy with the app and found it funny. All children thought that having the app in the waiting room during a dental visit would be useful. CONCLUSIONS: The findings confirmed that the app is usable and provides an excellent user experience. Our children-adapted methodology contributes to achieving usable mobile-based products for children with a highly scored user experience.

Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach.

Introduction: The influence of pre-existing humoral immunity, inter-individual demographic factors, and vaccine-associated reactogenicity on immunogenicity following COVID vaccination remains poorly understood. Methods: Ten-fold cross-validated least absolute shrinkage and selection operator (LASSO) and linear mixed effects models were used to evaluate symptoms experienced by COVID+ participants during natural infection and following SARS-CoV-2 mRNA vaccination along with demographics as predictors for antibody (AB) responses to recombinant spike protein in a longitudinal cohort study. Results: In previously infected individuals (n=33), AB were more durable and robust following primary vaccination when compared to natural infection alone. Higher AB were associated with experiencing dyspnea during natural infection, as was the total number of symptoms reported during the COVID-19 disease course. Both local and systemic symptoms following 1st and 2nd dose (n=49 and 48, respectively) of SARS-CoV-2 mRNA vaccines were predictive of higher AB after vaccination. Lastly, there was a significant temporal relationship between AB and days since infection or vaccination, suggesting that vaccination in COVID+ individuals is associated with a more robust immune response. Discussion: Experiencing systemic and local symptoms post-vaccine was suggestive of higher AB, which may confer greater protection.

Physiological demands and motion analysis of elite foil fencing.

The aim of this study was to determine the physiological demands and motion analysis of a simulated fencing competition. Eighteen fencers each completed 5 'poule' (5 touches) and 'direct elimination (DE)' (15 touches) fights. Expired gases were measured during 1 poule and DE fight. Heart rate (HR), ratings of perceived exertion (RPE) and movement data were recorded throughout all fights. Motion analysis was undertaken using the software LINCE PLUS. Differences between poule and DE fights were determined by either a paired t-test or a one-way repeated measures ANOVA. HR and RPE were significantly greater during DE compared to poule (170 ±10 vs 163 ±13 beats·min-1; P<0.05). A greater distance was covered during a DE fight compared to a poule fight (459.9 ± 117.7 m vs 162.6 ± 74.2 m; P<0.05). The average values of [Formula: see text] were 42.5 ±5.6 ml·kg-1·min-1 in men and 34.4 ±3.2 ml·kg-1·min-1 in women. Work-to-rest ratios reduced during the DE fights along with a lower average speed and increased max speed (11.7 ± 2.8 km∙h-1 vs 9.6 ± 1.6 km∙h-1; P<0.05). In conclusion, there is an increased physiological demand during a DE fight accompanied by a reduction in average speed and decreased work-to-rest ratio.

Ultra-Endurance Participation and Acute Kidney Injury: A Narrative Review.

Increasingly popular, ultra-endurance participation exposes athletes to extremely high levels of functional and structural damage. Ultra-endurance athletes commonly develop acute kidney injury (AKI) and other pathologies harmful to kidney health. There is strong evidence that non-steroidal anti-inflammatory drugs, common amongst ultra-athletes, is linked to increased risk and severity of AKI and potentially ischaemic renal injury, i.e., acute tubular necrosis. Ultra-endurance participation also increases the risk of exertional rhabdomyolysis, exercise-associated hyponatremia, and gastrointestinal symptoms, interlinked pathologies all with potential to increase the risk of AKI. Hydration and fuelling both also play a role with the development of multiple pathologies and ultimately AKI, highlighting the need for individualised nutritional and hydration plans to promote athlete health. Faster athletes, supplementing nitrates, and being female also increase the risk of developing AKI in this setting. Serum creatinine criteria do not provide the best indicator for AKI for ultra-athletes therefore further investigations are needed to assess the practicality and accuracy of new renal biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL). The potential of recurring episodes of AKI provide need for further research to assess the longitudinal renal health impact of ultra-participation to provide appropriate advice to athletes, coaches, medical staff, and event organisers.

Changes to Physical Activity, Sitting Time, Eating Behaviours and Barriers to Exercise during the First COVID-19 'Lockdown' in an English Cohort.

This study aimed to determine the effect of the first English national COVID-19 lockdown on physical activity (PA), sitting time, eating behaviours and body mass in an adult cohort. This was further examined to determine whether conforming to recommended guidelines on PA and sedentary behaviour was improved. Based on an online survey (n = 818) incorporating the International Physical Activity Questionnaire Short Form (IPAQ-SF), self-reported body mass change showed that in 32.2% of participants body mass increased, with 39.1% reporting an increase in food intake. Never exercising at the gym or undertaking an exercise class (online or live), increased by 50.8% during lockdown, with 53.5% changing from exercising frequently to never exercising, suggesting a lack of engagement with online and home workouts. However, outdoor running and cycling >2 times/week increased by 38% during lockdown. Walking at least 30 min continuously on >2 occasions/week increased by 70% during lockdown with minimum 10-min walks on 7 days per week increasing by 23%. The lockdown had a negative impact on sitting time (>8 h a day), which increased by 43.6% on weekdays and 121% at weekends. Furthermore, sitting <4 h/day decreased during lockdown (46.5% and 25.6% for weekdays and weekends, respectively). Those citing tiredness or lack of time as a barrier to exercise reduced by 16% and 60%, respectively, from pre-lockdown to during lockdown. More of the sedentary group met the Public Health England PA recommendations, however most participants still did not meet the UK Government guidelines for PA. Improvements in health per additional minutes of physical activity will be proportionately greater in those previously doing <30 min/week, the area where most improvements were found although, conversely sitting time was greatly increased. This study may assist in informing whether future lifestyle changes could improve the health of the population.

El papel de la ventilación no invasiva como tratamiento ventilatorio inicial en pacientes con neumonía y sin enfermedad pulmonar obstructiva crónica / Role of first-line noninvasive ventilation in Non-COPD subjects with pneumonia

Introducción: El uso de ventilación no invasiva (VNI) en pacientes sin EPOC con neumonía es motivo de controversia, debido a la elevada tasa de fracasos y a los efectos potencialmente nocivos de dicho fracaso. La finalidad de este estudio fue evaluar la evolución de los pacientes en función de cuál había sido el primer tipo de soporte ventilatorio aplicado, VNI o ventilación mecánica invasiva (VM), e identificar factores de predicción del fracaso de la VNI. Métodos: Estudio de una cohorte histórica de 159 pacientes sin EPOC con neumonía ingresados en la UCI que recibieron soporte ventilatorio. Los pacientes se clasificaron en dos grupos, VM invasiva y VNI. Se efectuaron análisis univariantes y multivariantes de los datos demográficos y clínicos. El análisis de mortalidad se ajustó por índice de propensión a ser conectado a VM invasiva como tratamiento inicial. Resultados: Ciento trece pacientes fueron conectados a VM invasiva como tratamiento ventilatorio inicial y 46 a VNI, 27 de los cuales precisaron intubación. La mortalidad hospitalaria fue del 35, 37 y 56%, respectivamente, y no se observaron diferencias significativas entre grupos. En el análisis ajustado a la propensión (expresada mediante (OR [IC 95%]), la mortalidad hospitalaria se asoció con la edad (1,05 [1,02-1,08]), la puntuación SAPS3 (1,03 [1,00-1,07]), la inmunosupresión (2,52 [1,02-6,27]) y el fracaso de la VNI, en comparación con la VM invasiva de primera línea (4,3 [1,33-13,94]). En comparación con la VM invasiva, el fracaso de la VNI retrasó la intubación (p=0,004), prolongó la duración de la VM invasiva (p=0,007) y la estancia en la UCI (p=0,001). El fracaso de la VNI se asoció con la necesidad de recibir fármacos vasoactivos (OR 7,8 [IC 95%, 1,8-33,2], p=0,006). Conclusiones: En pacientes sin EPOC con neumonía, la VNI como tratamiento ventilatorio inicial no se asoció con mejor evolución, en comparación con la VM invasiva de primera línea. El fracaso de la VNI se relacionó con duraciones más prolongadas de la MV y la estancia hospitalaria, y con mayor mortalidad hospitalaria. El uso de fármacos vasoactivos fue predictivo del fracaso de la VNI (AU)

Introduction: The use of noninvasive ventilation (NIV) in non-COPD patients with pneumonia is controversial due to its high rate of failure and the potentially harmful effects when NIV fails. The purpose of the study was to evaluate outcomes of the first ventilatory treatment applied, NIV or invasive mechanical ventilation (MV), and to identify predictors of NIV failure. Methods: Historical cohort study of 159 non-COPD patients with pneumonia admitted to the ICU with ventilatory support. Subjects were divided into 2 groups: invasive MV or NIV. Univariate and multivariate analyses with demographic and clinical data were performed. Analysis of mortality was adjusted for the propensity of receiving first-line invasive MV. Results: One hundred and thirteen subjects received first-line invasive MV and 46 received first-line NIV, of which 27 needed intubation. Hospital mortality was 35, 37 and 56%, respectively, with no significant differences among groups. In the propensity-adjusted analysis (expressed as OR [95% CI]), hospital mortality was associated with age (1.05 [1.02-1.08]), SAPS3 (1.03 [1.00-1.07]), immunosuppression (2.52 [1.02-6.27]) and NIV failure compared to first-line invasive MV (4.3 [1.33-13.94]). Compared with invasive MV, NIV failure delayed intubation (p=.004), and prolonged the length of invasive MV (p=.007) and ICU stay (p=.001). NIV failure was associated with need for vasoactive drugs (OR 7.8 [95% CI, 1.8-33.2], p=.006). Conclusions: In non-COPD subjects with pneumonia, first-line NIV was not associated with better outcome compared with first-line invasive MV. NIV failure was associated with longer duration of MV and hospital stay, and with increased hospital mortality. The use of vasoactive drugs predicted NIV failure (AU)

Role of First-Line Noninvasive Ventilation in Non-COPD Subjects With Pneumonia. / El papel de la ventilación no invasiva como tratamiento ventilatorio inicial en pacientes con neumonía y sin enfermedad pulmonar obstructiva crónica.

INTRODUCTION: The use of noninvasive ventilation (NIV) in non-COPD patients with pneumonia is controversial due to its high rate of failure and the potentially harmful effects when NIV fails. The purpose of the study was to evaluate outcomes of the first ventilatory treatment applied, NIV or invasive mechanical ventilation (MV), and to identify predictors of NIV failure. METHODS: Historical cohort study of 159 non-COPD patients with pneumonia admitted to the ICU with ventilatory support. Subjects were divided into 2 groups: invasive MV or NIV. Univariate and multivariate analyses with demographic and clinical data were performed. Analysis of mortality was adjusted for the propensity of receiving first-line invasive MV. RESULTS: One hundred and thirteen subjects received first-line invasive MV and 46 received first-line NIV, of which 27 needed intubation. Hospital mortality was 35, 37 and 56%, respectively, with no significant differences among groups. In the propensity-adjusted analysis (expressed as OR [95% CI]), hospital mortality was associated with age (1.05 [1.02-1.08]), SAPS3 (1.03 [1.00-1.07]), immunosuppression (2.52 [1.02-6.27]) and NIV failure compared to first-line invasive MV (4.3 [1.33-13.94]). Compared with invasive MV, NIV failure delayed intubation (p=.004), and prolonged the length of invasive MV (p=.007) and ICU stay (p=.001). NIV failure was associated with need for vasoactive drugs (OR 7.8 [95% CI, 1.8-33.2], p=.006). CONCLUSIONS: In non-COPD subjects with pneumonia, first-line NIV was not associated with better outcome compared with first-line invasive MV. NIV failure was associated with longer duration of MV and hospital stay, and with increased hospital mortality. The use of vasoactive drugs predicted NIV failure.

Laboratório de técnicas projetivas: projeciotécnica parapedagógica

Este artigo visa descrever as atividades do curso Laboratório de Técnicas Projetivas (LTP), embasado na abordagem científica da Projeciologia. Objetiva ainda a apresentação dos resultados obtidos por alunos participantes de 4LTPs, ministrado pelos professores autores deste artigo, no período de pouco mais de 1 ano. Evidencia-se a importância das técnicas projetivas nos cursos regulares de Projeciologia(AU)